“Mon Hémophilie” wins at the IMA
« Mon Hémophilie », the information website for haemophilia patients and their friends and family designed by Emakina for Baxter, took first prize at the latest Interactive Media Awards.
“Mon hémophilie” was designed as an information and support platform for haemophilia patients and their friends and family. The website contains clear and complete information about this hereditary illness and is adapted to the needs of patients and their specific situation in different phases of their life.
“Mon hémophilie” also offers video testimonials of patients talking about their experiences and interviews with specialists.
In addition, the website offers a handy “toolbox” with practical information cards to download, useful links and addresses, and answers to the questions most frequently asked by visitors.
“We are immensely proud of this award, which is the crowning of a project dedicated to offering high-quality information with respect for the patient,” says Vanessa Counaert, Senior Product Manager Haemophilia at Baxter. “With this website Baxter shows its dedication to the search for a better way to control and treat haemophilia.”
The international IMA jury gave the information platform 489 out of a possible 500 points and presented it with a “Best in Class Award” (equivalent of Gold). “Mon hémophilie” was chosen from among 65 contenders in the category “Pharmaceutical.” The jury based the score and its decision on five specific criteria: its content, its design, its functionalities, its usability, and its conformity to standards.
The Interactive Media Awards take place in the US every year; they reward the best creative campaigns on the Internet worldwide.
Our recent blog posts
See all blogs-
How is AI’s synthetic data enhancing User Experience Research? Technology
-
Web3.AI Rising : How new technology can add value to your business
-
How generative AI helped us create an e-commerce app – with personalised content – in just 2 weeks Technology
-
Can you build a foodie app in 3 days using Generative AI? (Spoiler alert: yes!)